[1]
Atalay, S. et al. 2021. Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice. Acta Dermato-Venereologica. 101, 5 (May 2021), adv00463. DOI:https://doi.org/10.2340/00015555-3815.